179 related articles for article (PubMed ID: 1088898)
1. Narcotic antagonists: naltrexone progress report: foreword.
Jaffe J
NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
[No Abstract] [Full Text] [Related]
2. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
Resnick RB; Schuyten-Resnick E; Washton AM
Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
[No Abstract] [Full Text] [Related]
3. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
Martin WR
NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
[No Abstract] [Full Text] [Related]
4. The role of the federal government in the development of narcotic antagonists.
Green AI
Adv Biochem Psychopharmacol; 1973; 8(0):576-7. PubMed ID: 4795123
[No Abstract] [Full Text] [Related]
5. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone implants as treatment for heroin dependence: part I.
Byrne A; Graham G; Hallinan R; Murnion B
Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
[No Abstract] [Full Text] [Related]
7. Research on naltrexone in the criminal justice system.
Patapis NS; Nordstrom BR
J Subst Abuse Treat; 2006 Sep; 31(2):113-5. PubMed ID: 16919735
[TBL] [Abstract][Full Text] [Related]
8. The clinical usefulness of narcotic antagonists: implications of behavioral research.
Meyer RE; Mirin SM; Altman JL
Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
[No Abstract] [Full Text] [Related]
9. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
Poser W; Ehrenreich H
Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
[No Abstract] [Full Text] [Related]
10. Methadone maintenance and narcotic blocking drugs.
Wikler A
Int J Addict; 1977 Oct; 12(7):851-6. PubMed ID: 201577
[TBL] [Abstract][Full Text] [Related]
11. NIDA's naltrexone research program.
Julius D
NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
[No Abstract] [Full Text] [Related]
12. [Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
Heilig M
Lakartidningen; 2002 Jan; 99(3):200-4. PubMed ID: 11838078
[No Abstract] [Full Text] [Related]
13. Treatment of heroin-dependent persons with antagonists: current status.
Renault PF
NIDA Res Monogr; 1981; 28():11-22. PubMed ID: 6791000
[TBL] [Abstract][Full Text] [Related]
14. The use of cyclazocine in the treatment of heroin addicts.
Petursson ES; Preble E
Dis Nerv Syst; 1970 Aug; 31(8):549-51. PubMed ID: 5471792
[No Abstract] [Full Text] [Related]
15. Regarding naltrexone for probationers and parolees.
Stancliff S
J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
[No Abstract] [Full Text] [Related]
16. Naltrexone as a "mandate" or as a choice comments on "Judicially mandated naltrexone use by criminal offenders: a legal analysis".
Presenza LJ
J Subst Abuse Treat; 2006 Sep; 31(2):129-30. PubMed ID: 16919738
[No Abstract] [Full Text] [Related]
17. Pharmacological adjuncts in the treatment of opiate dependence.
Resnick RB
Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
[No Abstract] [Full Text] [Related]
18. The use of depot naltrexone under legal coercion: the case for caution.
Hall W; Capps B; Carter A
Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728
[No Abstract] [Full Text] [Related]
19. Cyclazocine and methadone in narcotic addiction.
Freedman AM; Fink M; Sharoff R; Zaks A
JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
[No Abstract] [Full Text] [Related]
20. A unit for delivering multiple drug treatment and prevention services.
Hosp Community Psychiatry; 1975 Oct; 26(10):663-6. PubMed ID: 1201850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
